Aventura Neurological Associates, PA
Aventura, Florida 33180
We've found
1 trials
at this facility
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
